Acepodia, Inc. Acepodia, Inc.

Acepodia, Inc.

6976

Rank in Stocks #16386
Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering... Acepodia, Inc. is an advanced-stage biotechnology firm focused on pioneering cell-based treatments. The company utilizes its distinctive Antibody Cell Conjugation (ACC) platform technology to innovate therapeutic approaches and address critical unmet needs in oncology. Through this proprietary method, Acepodia engineers novel ACE therapies by precisely attaching tumor-specific antibodies to its specialized immune cells, such as gamma delta 2 T cells. Established in 2017, the company's corporate headquarters are situated in Grand Cayman, Cayman Islands.
Share Price
$0.36733773
Last synced: 2026-11-10
Market Cap
$213.26M
Change (1 day)
-2.43%
Change (1 year)
-25.63%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Acepodia, Inc. (6976)
Operating Margin as of November 2026 TTM: 0.00%
According to Acepodia, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of -523,891.89%.
Operating Margin history for Acepodia, Inc. from 2020 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% -100.00%
2025 -523,891.89% 195.16%
2024 -177,493.91% 6,655.34%
2023 -2,627.46% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
-149.01% -
US
25.57% -
AU
31.23% -
BE
29.35% -
NL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Acepodia, Inc.'s operating margin

What was Acepodia, Inc.'s operating margin in 2025?

In 2025, Acepodia, Inc.'s operating margin was -523,891.89%, compared with -177,493.91% in 2024.

How has Acepodia, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Acepodia, Inc.'s operating margin was highest in 2022 (0.00%) and lowest in 2025 (-523,891.89%).

How does Acepodia, Inc.'s operating margin compare with similar companies?

Acepodia, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.